Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Eva Vidacs

HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors

Cancer Research

Cancer Research

English

Related publications

Salmonella Exploits NLRP12-dependent Innate Immune Signaling to Suppress Host Defenses During Infection

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Host Histone Acetylation Unlocks HDAC Inhibitor Potential

English

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

Cell Host and Microbe

Molecular Biology

Cancer Research

English

Dengue Virus and the Host Innate Immune Response

Emerging Microbes and Infections

Infectious Diseases

English

The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin

Clinical Cancer Research

Cancer Research

English

Inhibitors of HSP90 Block P95-Her2 Signaling in Trastuzumab-Resistant Tumors and Suppress Their Growth

Cancer Research

Molecular Biology

English

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

Journal of Cancer

English

Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer

English